For how we live.
Gavi is funding a standing mpox vaccine stockpile, coordinated by the same group that manages emergency supplies for cholera, yellow fever and Ebola, to avoid repeating the 2022 access gap.
Twenty-two years of national data show income-related inequities in care use narrowing, and copayment increases for higher earners not reversing that. Services carrying extra user charges are the outlier.
The estimate covers 2000 to 2023 and 108 countries. It is a counterfactual model, not a measured saving, and it lands as the US and other donors debate cutting the disease-specific funding it credits.
The estimate covers only populations in humanitarian need across Burkina Faso, Central African Republic, Chad, Mali, Niger and Nigeria — and it assumes nothing replaces the lost money.
WHO and the World Bank put the global service coverage index at 71, up from 54 in 2000. On current trends it reaches only 74 by 2030.
A national pharmaceutical database analysis found out-of-pocket purchases accounted for 78-86% of contraceptive use, with emergency contraception priced up to 25 times higher than the insured rate.
WHO's Global Tuberculosis Report 2025 counts 10.7 million people ill and over 1.2 million dead last year. Available funding is US$5.9 billion against a US$22 billion annual target.
Across 165 clinics in four African countries, HIV testing fell by up to 35% and treatment starts by up to 32%. Most services had not returned to baseline two months after the orders were lifted.